0001495388-17-000001.txt : 20170214 0001495388-17-000001.hdr.sgml : 20170214 20170214142054 ACCESSION NUMBER: 0001495388-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170214 DATE AS OF CHANGE: 20170214 EFFECTIVENESS DATE: 20170214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HemoSonics, LLC CENTRAL INDEX KEY: 0001495388 IRS NUMBER: 000000000 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-280662 FILM NUMBER: 17607038 BUSINESS ADDRESS: STREET 1: 400 PRESTON AVE CITY: CHARLOTTESVILLE STATE: VA ZIP: 22903 BUSINESS PHONE: 434-202-1032 MAIL ADDRESS: STREET 1: 400 PRESTON AVE CITY: CHARLOTTESVILLE STATE: VA ZIP: 22903 D 1 primary_doc.xml X0707 D LIVE 0001495388 HemoSonics, LLC 400 PRESTON AVE Suite 250 CHARLOTTESVILLE VA VIRGINIA 22903 434-202-1032 VIRGINIA None None Limited Liability Company true Timothy Fischer 400 Preston Ave Suite 250 Charlottesville VA VIRGINIA 22903 Executive Officer Director Manager William F. Walker 400 Preston Ave Suite 250 Charlottesville VA VIRGINIA 22903 Director Manager Francesco Viola 400 Preston Avenue Suite 250 Charlottesville VA VIRGINIA 22903 Executive Officer Director Manager Mark Wheeler 400 Preston Ave Suite 250 Charlottesville VA VIRGINIA 22903 Director Manager William P. Moffitt 400 Preston Ave Suite 250 Charlottesville VA VIRGINIA 22903 Director Manager Josep Manent 400 Preston Ave Suite 250 Charlottesville VA VIRGINIA 22903 Director Manager Philippe Barroux 400 Preston Ave Suite 250 Charlottesville VA VIRGINIA 22903 Director Manager Antoine Coulot 400 Preston Ave Suite 250 Charlottesville VA VIRGINIA 22903 Director Manager Other Health Care Decline to Disclose 06b false 2017-01-31 false true false 0 Ferghana Securities Inc. 43430 E. Hunterson Henrie, II 2431896 420 Lexington Avenue Suite 4740 New York NY NEW YORK 10170 true 15000000 15000000 0 false 1 1058685 0 Represents total commissions paid in combination of cash and warrants. 0 Proceeds are used for general working capital, which may include normal compensation to executive officers/managers. false HemoSonics, LLC Timothy J. Fischer Timothy J. Fischer President and CEO 2017-02-14